Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002554552 | SCV001233873 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327358 | SCV002626721 | likely benign | Hereditary cancer-predisposing syndrome | 2020-06-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001068742 | SCV002085909 | uncertain significance | Fumarase deficiency | 2021-08-10 | no assertion criteria provided | clinical testing |